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Abstract.  Nerve growth factor (NGF) promotes neu- 
ronal differentiation of PC12 pheochromocytoma cells. 
One of the most prominent and distinguishing  features 
of neuronal  differentiation is neurite outgrowth.  The 
mechanism by which NGF causes the cells to elab- 
orate neurites is unknown.  This study shows that 
K-252a, a potent protein kinase inhibitor,  blocks NGF- 
induced neurite outgrowth and the changes in protein 
phosphorylation elicited by NGE In the experiment 
with intact cells phosphorylated with 32p-orthophos- 
phoric acid, an exposure of PC12h cells to NGF (50 
ng/ml)  caused an increase in the phosphorylation of 
tyrosine hydroxylase and a 35,000-D protein and a de- 
crease in a  36,500-D protein.  Pretreatment of PC12h 
cells with K-252a (100 nM) inhibited the effects of 
NGF on the phosphorylation of these three proteins. 
In the phosphorylation of cell-free extracts with [T-32p] 
ATP,  treatment of PC12h cells with NGF (50 ng/mi) 
caused a decrease in the phosphorylation of Nspl00. 
Pretreatment of the cells with K-252a (30 nM) almost 
completely blocked the NGF effect on the phosphory- 
lation of Nspl00 elicited by subsequent treatment of 
the cells with NGF.  Treatment of PC12h cells with 
NGF promoted outgrowth of neurites.  The addition of 
K-252a (100 nM) into the culture almost completely 
blocked the generation of neurites elicited by NGE 
Earlier studies demonstrated that NGF-induced neurite 
outgrowth in PC12 cells involves at least two compo- 
nents:  the first of these is transcription-dependent  and 
the second is transcription-independent.  To determine 
the component on which K-252a acts, experiments 
were carried out on NGF-induced priming or regener- 
ation of neurites.  When K-252a was present in the 
priming  step,  NGF induced only actinomycin D-sensi- 
tive neurites,  showing that K-252a interferes with the 
transcription-dependent  actions of NGE When already 
primed cells were treated with NGF, actinomycin D-re- 
sistant neurites were formed and these were blocked 
by K-252a,  showing that the inhibitor interferes with 
the transcription-independent  actions of NGF as well. 
Although the exact mechanism of inhibition  of NGF- 
promoted neurite formation by K-252a is unknown, 
the most probable explanation  is that both transcrip- 
tion-dependent and -independent components are in- 
volved in at least one step of the activation of some 
specific protein kinase(s) that can be suppressed by 
K-252a. 
N 
'P.RVE growth factor (NGF)  ~  is a polypeptide required 
for the survival and development of sympathetic and 
sensory nervous  systems (9, 21, 29). The rat pheo- 
chromocytoma cell line PC12 has become the premier model 
for studying  the mechanism of action of NGE  NGF pro- 
motes neuronal  differentiation  of PC12 cells.  That is, PC12 
cells respond to NGF over a period of days by their biochem- 
ical  and  morphological  conversion  from  chromatfin-like 
cells to those with a sympathetic neuron-like  phenotype that 
includes neurite outgrowth,  electrical excitability, and cessa- 
tion of cell growth (6, 10). These actions are initiated by the 
binding  of NGF to its specific receptors on the surface of 
1.  Abbreviations  used  in  this paper:  dBeAMP,  N,2'-dibutyryladenosine 
3',5"cyclic  monophosphate; NGF, nerve growth factor; Nsp, nerve growth 
factor-sensitive protein; SMP,  slow-migrating  protein. 
PC12 cells.  Although  the exact mechanism of signal trans- 
duction after the interaction  of NGF with its receptor is un- 
known,  some kind of second messenger system must be in- 
volved (16). 
The regulation of intracellular  events by extracellular  sig- 
nals often involves reversible covalent modification of proteins. 
One of the most notable modifications  is protein phosphory- 
lation. Indeed, NGF regulates the intracellular  phosphoryla- 
tion  of several  proteins.  These  proteins  include  tyrosine 
hydroxylase  (12), a 30,000-D nuclear protein  (slow-migrat- 
ing protein [SMP]; 25, 33), a 35,000-D insoluble protein (14), 
a 100,000-D nerve growth factor-sensitive protein (Nspl00; 
7, 8),  the ribosomal protein $6 (12, 23), and a 250,000-D 
cytoskeletal  protein (20).  With  respect to these actions of 
NGF, it has also been reported that in PC12 cells NGF alters 
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SMP kinase (25), NGF-sensitive $6 kinase (22),  kinase N 
(27),  cAMP-dependent  protein  kinase  (5,  12,  24),  and 
Ca2+/phospholipid-dependent protein kinase (C kinase;  5, 
13). It appears that a variety of  biochemical and morphologi- 
cal changes accompanied by the NGF-induced neuronal dif- 
ferentiation is mediated at least in part by such modulation 
of protein phosphorylation. 
It has been reported that K-252a, a microbial alkaloid iso- 
lated from the culture broth of Nocardiopsis species, is a po- 
tent inhibitor of C kinase and cyclic nucleotide-dependent 
protein kinases.  This compound inhibits these protein ki- 
nases competitively with respect to ATP (17). Therefore, it 
was expected that this kinase inhibitor would provide a useful 
tool for studies on changes in the phosphorylation of  proteins 
and on other biological actions elicited by NGE In this study, 
it is shown that K-252a blocks the NGF-mediated changes in 
the phosphorylation of proteins and neurite outgrowth. 
Materials and Methods 
Materials 
NGF (2.5 s) was prepared by the procedure of Bocchini and Angeletti (1). 
K-252a  was  purchased  from  Kyowa  Medex  Co.,  Ltd.  (Tokyo,  Japan). 
N,2'-dibutyryladenosine Y,5'-cyclic monophosphate (dBcAMP) was pur- 
chased from Sigma Chemical Co.  (St. Louis, MO).  Actinomycin D  was 
purchased  from Seikagaku  Kogyo Co.,  Ltd.  (Tokyo,  Japan).  32p-ortho- 
phosphoric acid and [y-32p  I ATP were obtained from New England Nu- 
clear (Boston, MA). SDS-PAGE molecular mass standards were from Bio- 
Rad Laboratories (Cambridge, MA). 
Cell Culture 
PC12 subclone h cells (15) were grown in DME supplemented with 7 % FBS 
and 7 % horse serum. They were kept in a humidified atmosphere containing 
95% air and 5% CO2 in 75-cm  2 tissue culture flasks or 35-mm tissue cul- 
ture dishes at 37°C. The cells were subcultured once a week at a  1:6 or 1:8 
split ratio, and the culture medium was changed once a week. 
Phosphorylation  in Intact Cells 
The phosphorylation was accomplished by the incubation of PC12h cells 
with 32p-orthophosphoric acid at a concentration of 100 IxCi/ml  for 2 h. 
NGF treatment was carried out by incubating the cells with NGF for the 
final  1 h of the 2-h labeling period, When used, K-252a was added to the 
culture 15 min before NGF addition. After the incubation, the medium was 
removed and cells were collected and washed with buffer A (composed of 
0.32 M sucrose containing 3 mM CaCI2,  1 mM MgCI2, and 1 mM sodium 
phosphate, pH 6.5).  Then the cells were suspended in 1 ml of lysis buffer 
composed of 0.24  M  sucrose,  20  mM  Na2MoO4,  5  mM  ethylenedi- 
aminetetraacetate, and  10 mM sodium phosphate (pH 6.5),  containing 1 
mM phenylmethylsulfonyl fluoride (PMSF) and 0.2 % Triton X-100, and left 
on ice for 15 rain. The lysates were centrifuged at  1,500 g for 10 min to 
remove the crude nuclear fraction. The supernatants were then centrifuged 
at 100,000 g for 60 min to separate the soluble fraction from the insoluble 
fraction. The final supernatants and the insoluble pellets were, respectively, 
diluted with or dissolved in 1 ml of SDS sample buffer,  then heated in a 
boiling water bath for 5 min. 
Normalization of  Protein-bound Radioactivity 
The protein-bound counts of 32p in each sample were measured by spotting 
portions of the sample 1.5 cm above the bottom edge of small strips (12  × 
1.5 cm) of a filter paper (Toyo No. 526) and chromatographing the strips 
in an ascending fashion for 10 min in 25% TCA. The strips were dried and 
the portions containing the origins were counted in Atomlight scintillation 
fluid (New England Nuclear, Boston, MA). 
Phosphorylation in Cell-free Extracts 
Culture medium was removed and PC12h cells were washed with, and then 
incubated in, DME without serum. The cells were treated with NGF for 
3 h  at a concentration of 50 ng/ml in the culture flasks.  Pretreatment of 
PCI2h cells with K-252a was carried out by the addition of K-252a at con- 
centrations from 3 to 100 nM 1 h before NGF addition. At the end of the 
experiment, the medium was removed and the cells were collected and 
washed with buffer A. The cell pellets were taken up in 700 ~tl to 1 ml of 
sonication buffer consisting of 100 mM Pipes, pH 6.9,  1 mM MgSO4,  0.1 
mM Na2MoO4,  10 mM EGTA, and 1 mM PMSF. The cell suspension was 
sonicated for 30 s (sonifier model No. 200; Branson Sonic Power Co., Dan- 
bury, CT) and centrifuged at 100,000 g for 60 rain. The supernatant frac- 
tions were stored frozen at  -80°C until assayed. The supernatants were 
diluted to an equal concentration of protein and the phosphorylation was 
carried out as described previously (8,  14).  Protein determinations were 
done by the method of Bradford (2).  The incubation mixture contained 
50  mM  2-(N-morpholino)ethanesulfonic acid  (MES;  pH  6.2),  10  mM 
MgSO4,  0.1 mM Na2MoO4,  and 2-4 IxCi of [T-32p]ATP in a final volume 
of 200 ~tl. The incubations were carried out at 37°C for 10 min and termi- 
nated by the addition of 200 ~tl of SDS sample buffer.  After being boiled, 
the samples were subjected to SDS-PAGE. 
PAGE 
SDS-PAGE was performed at 150 V for 5-6 h using 10% or 7.5% acryl- 
amide slab gel containing 0.1% SDS (19). Gels were stained overnight with 
Coomassie Blue staining solution (0.25 % Coomassie Blue in 9 % acetic acid 
and 45% ethanol) and destained initially with 42% ethanol and 7% acetic 
acid and finally with 7 % acetic acid. 
Autoradiography 
The slab gels were dried in vacuo and exposed to XAR-5 film (Eastman Ko- 
dak Co., Rochester, NY) at room temperature. After an appropriate period 
of time, the film was processed using standard procedures. Autoradiograms 
were scanned using a Shimadzu CS-900, and the areas under the relevant 
peaks were measured. 
Results 
Effect of  Pretreatment with K-252a on the Action of 
NGF or of Dibutyryl cAMP in the Phosphorylation of 
Proteins in Intact PC12h Cells 
The  incubation  of PC12h  cells  with  32p-orthophosphoric 
acid led to phosphorylation of a number of proteins, includ- 
ing three with apparent molecular masses of 60,000, 36,500, 
and 35,000 D. Treatment of PC12h cells with NGF (50 ng/ 
ml) in culture caused an increase in the incorporation of 32p 
into the 60,000- and 35,000-D proteins, and a decrease in the 
36,500-D protein. Of these, the 60,000-D  protein has been 
identified as  tyrosine hydroxylase (12,  14).  Treatment of 
PC12h cells with K-252a produced no marked alterations in 
the phosphorylation of proteins except tyrosine hydroxylase. 
The phosphorylation of this enzyme was  reduced by the 
treatment with K-252a at concentrations >300 nM in a dose- 
dependent manner (Figs.  1 A and 2 A, and Table I). Next, 
the effect of pretreatment with K-252a on NGF-mediated 
changes in the phosphorylation of proteins in PC12h cells 
was examined. Pretreatment of PC12h cells with K-252a in- 
hibited the effects of NGF on the phosphorylation of these 
proteins. The inhibition was observed when the cells were 
treated with K-252a at concentrations >100 riM, and almost 
complete inhibition was obtained at 1 IxM (Fig. 1, A and B, 
and Table I). On the other hand, treatment of PC12h cells 
with dibutyryl cAMP (300 lxM) also caused an increase in 
The Journal  of Cell Biology,  Volume 107, 1988  1532 Figure 1.  Effect of pretreatment with K-252a on the action of NGF in the phosphorylation of proteins in intact PCI2h cells. PCI2h cells 
were labeled with 3zP-orthophosphoric acid (100 laCi/ml) in DME supplemented with 7%  FBS and 7% horse serum for 120 min. A and 
B are autoradiograms from SDS-PAGE (10%) of respective 0.2% Triton X-100 detergent-soluble and -insoluble fractions from PC12h cells 
treated with control culture medium for the 120-min labeling period (C) or with NGF (50 ng/ml) for the last 60 min of the 120-min labeling 
(N). As indicated, other similar cultures received various concentrations of K-252a (100 nM, 300 nM, or l  laM) that was present during 
the last 75 rain of the  120-min labeling period. In A, the arrow indicates the position of the 60,000-D protein. The relative densities of 
the 60,000-D protein band were as follows: (C)  100;  (N)  140; (100 nM [C])  104;  (100 nM [NI)  125;  (300 nM [C]) 88; (300 nM IN]) 
98; (1/tin [C]) 70; (1/zM IN]) 62. In B, the upper and lower arrows indicate the position of 36,500- and 35,000-D  proteins, respectively. 
The relative densities of the 36,500-D protein band were as follows: (C)  100; (N) 75;  (100 nM [C]) 96; (100 nM IN]) 87; (300 nM [C]) 
99; (300 nM IN]) 97; ( 1/tM [C]) 94; (1/tM IN]) 96. The relative densities of the 35,000-D  protein band were as follows; (C) 100; (N) 
320; (100 nM [C]) 100; (100 nM [N]) 220; (300 nM [C]) 80; (300 nM [N]) 120; (1/.tM [C]) 80; (1/zM IN]) 80. (Values for the 35,000-D 
protein bands were rounded off since the density of the band for this protein from PC12h cells incubated in control culture medium was 
very low.) 
Figure 2.  Effect of pretreatment with K-252a on the action of dibutyryl cAMP in the phosphorylation of proteins in intact PC12h  cells. 
PC12h  cells were labeled with 32p-orthophosphoric acid in DME supplemented with 7% FBS and 7% horse serum for 120 min. A and 
B are autoradiograms from SDS-PAGE (10%) of respective 0.2% Triton X-100 detergent-soluble and -insoluble fractions from PC12h cells 
treated with control culture medium for the 120-min labeling period (C) or with dBcAMP (300 ~tM) for the last 60 min of the labeling 
period (dBc). As indicated, other similar cultures received various concentrations of K-252a (300 nM, 1 wM, or 3 I~M) that were present 
during the last 75 min of the 120-rain labeling period. In A, the arrow indicates the position of the 60,000-D protein. The relative densities 
of the 60,000-D protein band were as follows: (C) 100; (dBc)  113; (300 nM [C]) 87; (300 nM [dBc]) 102; (1/tM [C]) 69; (1 ltM [dBc]) 
81; (3/JM [C]) 49; (3 ltM [dBc]) 54. In B, the upper and lower arrows indicate the position of 36,500- and 35,000-D proteins, respectively. 
The relative densities of the 36,500-D protein band were as follows: (C)  100; (dBc) 91; (300 nM [C]) 102;  (300 nM [dBc]) 90; (1/zM 
[C]) 99; (1 ltM [dBc]) 90;  (3/zM [C])  105; (3 ltM [dBc]) 92. The relative densities of the 35,000-D  protein band were as follows: (C) 
100; (dBc) 210; (300 nM [C]) 100; (300 nM [dBc]) 180; (1 laM [C]) 100; (1 IzM [dBc]) 130; (3/zM [C]) 90; (3 ltM [dBc]) 100. (Values 
for these densities were rounded off as in the legend of Fig.  1.) 
Hashimoto Blockage of NGF Actions by K-252a  1533 Table L Phosphorylation of  Proteins Extracted from PC12h Cells 
Pretreatment with K-252a 
None (n = 7)  100 nM (n =  3)  300 nM (n =  3)  1,000 nM (n = 4) 
Protein  control  NGF  control  NGF  control  NGF  control  NGF 
60,000-D  100  152 +  29  102 +  9  134 +  16  83  +  8  94 +  3  75  +  14  71  +  10 
36,500-D  100  77 -t- 9  97  +  5  86 +  6  99  +  7  95  +  9  99 ±  8  98  ±  5 
35,000-D  100  261  ±  44  103  ±  6  183  ±  32  93  ±  12  110 +  10  90 +  8  90 +  14 
PC  12h cells were pretreated with various  concentrations  of K-252a, then treated with or without NGF at a concentration  of 50 ng/ml. Relative  density of 60,000-, 
36,500-, and 35,000-D  protein  bands were  measured  by densitometry  (see Materials and Methods)  of autoradiograms, and are expressed as a percentage  of untreat- 
ed control values taken as 100%. The values represent the averages ±  SD of 7, 4, or 3 determinations, as indicated. 
the  incorporation  of 32p  into  tyrosine  hydroxylase  and  a 
protein that migrated at a position of an apparent molecular 
mass of 35,000 D on an SDS gel (Fig. 2, A and B). The effect 
of dibutyryl cAMP on the phosphorylation of the 36,500-D 
protein was not clear. Although the pretreatment of the ceils 
with K-252a also inhibited the effects of dibutyryl cAMP on 
the phosphorylation of these proteins, much higher concen- 
trations of the inhibitor were required  (Fig.  2,  A and B). 
Effect of  Pretreatment with K-252a on Subsequent 
Cell-free Phosphorylation of  Soluble Proteins  from 
Control PC12h Cells or Cells Treated with NGF 
The incubation  of soluble  extracts  from PC12h cells  with 
[7-32p]ATP led to phosphorylation of a number of proteins, 
including one with an apparent molecular mass of 100,000 D, 
Figure 3.  Effect of pretreatment  with  K-252a  on subsequent  cell- 
free phosphorylation of soluble proteins from control PCI2h cells 
or cells treated  with NGE Cells were treated  with control culture 
medium (C) or NGF (N; 50 ng/ml)  for 3 h.  1 h before the start 
of incubation,  some of the cultures  were given K-252a at a concen- 
tration of 3 or 30 nM. The cultures were then sonicated,  and soluble 
extracts  were  obtained by centrifugation.  The  extracts  were  in- 
cubated with [~/-32P]ATP  for 10 min at 37°C. The reactions  were 
terminated  by addition  of SDS sample buffer, and incubation mix- 
tures  were boiled and applied  to 7.5% SDS polyacrylamide gels. 
The gels were stained,  destained,  dried, and then exposed to x-ray 
film for the appropriate time.  The arrow indicates  the position of 
Nspl00. The relative densities  of the Nspl00 band were as follows: 
(C)  100; (N) 74; (3 nM [C])  140; (3 nM [NI) 111; (30 nM [C]) 
120; (30 nM [N]) 137, 
designated  in  earlier  studies  as  Nspl00  (7,  8).  In extracts 
from  NGF-treated  cells,  phosphorylation  of Nspl00  was 
markedly and selectively reduced,  as described previously 
(14). In contrast, treatment of the cells with K-252a caused 
an  increase  in  the  phosphorylation  of Nspl00  during  the 
subsequent  incubation  of  the  extracts  with  [T-32p]  ATP. 
Pretreatment  of the cells  with K-252a prevented  the NGF 
effect on the  phosphorylation of Nspl00  at concentrations 
>3-10 nM, and almost complete inhibition was obtained at 
30 nM (Fig.  3). 
Effect of  K-252a on NGF-promoted Neurite Outgrowth 
When PC12h cells were cultured with NGF (50 ng/ml), the 
generation of neurites proceeded with a lag time of >24 h. 
NGF-promoted neurite outgrowth was inhibited by coaddi- 
tion of K-252a into the culture.  The inhibition was clearly 
observed when the cells were cultured with NGF in the pres- 
ence of K-252a at concentrations >30 nM and was almost 
complete at 100 nM (Fig. 4). Thus, the protein kinase inhibi- 
tor  K-252a  completely  inhibited  NGF-promoted  neurite 
outgrowth.  It has  been  demonstrated  that  NGF-promoted 
neurite outgrowth in PC12 cells involves at least two separ- 
able components: one of these requires RNA transcription, 
whereas  the  other  is  transcription  independent  (3).  The 
transcription-dependent component may lead to the specific 
synthesis  and  accumulation  of materials  required  for out- 
growth of neurites.  Accumulation of such materials appears 
to be necessary but not sufficient to promote generation of 
neurites (3). The transcription-independent component must 
be activated to promote generation and regeneration of neu- 
rites in the respective naive cells and NGF-pretreated cells. 
Therefore, the effect of K-252a on the respective transcrip- 
tion-dependent and -independent components in the mecha- 
nism of NGF-promoted neurite outgrowth was investigated. 
Effect of  K-252a on NGF-promoted Regeneration of 
Neurites from NGF-primed Cells 
After the exposure of PC12h cells  to NGF (50  ng/ml)  for 
8 d, the cells were triturated to shear off their neurites, then 
were subcultured with NGF. Most of cell clumps regenerated 
neurites within 24 h (Fig. 5 B). This regeneration of neurites 
was  inhibited  by  the  presence  of  K-252a  in  the  culture 
medium in a dose-dependent manner,  and almost complete 
inhibition was obtained at 100 nM (Fig. 5, D, E, and F). The 
measurement of neurite-bearing clumps was carried out by 
the counting of clumps with neuritic processes longer than 
twice the cell diameter.  A minimum of 115 clumps per cul- 
The Journal of Cell Biology, Volume 107, 1988  1534 Figure 4.  Effect of K-252a on NGF-promoted neurite outgrowth. PC12h cells were cultured for 8 d in control culture medium (A), in the 
presence of NGF (50 ng/ml; B), in the presence  of NGF (50 ng/mi) and K-252a (10 nM;  C), in the presence of NGF (50 ng/ml) and 
K-252a (30 nM; D), in the presence of NGF (50 ng/ml) and K-252a (100 nM; E), or in the presence of K-252a (I00 nM; F). Bar, 50 Ixm. 
ture was examined. After 1 d  in culture in the presence of 
NGF (50 ng/ml), 72.7%  of the clumps exhibited long neu- 
rites, in contrast to only 9.3 % short process-bearing clumps 
in untreated cultures. Coaddition of K-252a in NGF-treated 
cultures reduced the percentage of neurite-bearing clumps 
from 72.7% to 53.8, 42.6, or 13.1% at a concentration of 10, 
30,  or 100 nM, respectively, and suppressed the elongation 
of neurite length with increasing doses (Fig. 5). The data in- 
Hashimoto Blockage of NGF Actions by K-252a  1535 Figure 5. Effect of K-252a on NGF-promoted regeneration of neurites from NGF-primed  cells. NGF-primed  PCI2h cells that had been 
preexposed to NGF (50 ng/ml) for 8 d were subeultured in control medium without NGF (A), with NGF (50 ng/ml; B), with NGF plus; 
actinomycin D (1 riM; C), with NGF plus K-252a (10 nM; D), with NGF plus K-252a (30 nM; E), or with NGF plus K-252a (100 nM; 
F) for 24 h.  Bar, 50 ttm. 
dicated  that  K-252a  suppresses  NGF-induced  neurites  at 
concentrations higher than 10 riM. On the other hand, addi- 
tion  of actinomycin  D  to  the  culture  did  not  affect  the 
regeneration of neurites elicited by NGF (Fig.  5  C) as de- 
scribed in earlier studies (3,  11). These results indicate that 
K-252a  inhibits  the  transcription-independent  component 
that is involved in the mechanism of promotion of neurite 
outgrowth elicited by NGF. Then what was investigated was 
whether the presence of K-252a in the PC12h culture would 
inhibit the priming elicited by NGF. 
The Journal of Cell Biology, Volume 107,  1988  1536 Figure 6. Effect of K-252a on NGF-promoted priming. PCI2h cells were treated with NGF (50 ng/ml) plus K-252a (100 nM) for 8 d. Then 
the cells were washed three times with control culture  medium (DME supplemented with 7 % FBS and 7 % horse serum) and cultured 
in control medium for 24 (A) or 48 (D) h,  with NGF (50 ng/ml) for 24 (B) or 48 (E) h, or with NGF (50 ng/ml) plus actinomycin D 
(1  nM) for 24 (C) or 48 (F) h.  Bar, 50 I.tm. 
Effect of  K-252a on NGF-promoted Priming 
After the treatment of PC12h cells with NGF (50 ng/ml) plus 
K-252a (100 nM) for 8 d, the cells were cultured in the pres- 
ence or absence of NGF and/or actinomycin D. As shown in 
Fig. 6, NGF promoted short neurites within 24 h, and these 
neurites  extended  with time (Fig.  6,  B  and E).  However, 
coaddition of actinomycin D blocked NGF-dependent gener- 
ation of neurites (Fig. 6,  C and F). These data indicate that 
K-252a blocks a transcription-dependent component,  since 
an inhibitor of RNA synthesis, actinomycin D, blocked NGF- 
Hashimoto Blockage of NGF Actions by K-252a  1537 dependent neurite outgrowth in the cells that were preex- 
posed to NGF in the presence of K-252a for 8 d. 
Discussion 
The data presented here show that K-252a prevented the 
effects of NGF on phosphorylation of proteins and neurite 
outgrowth in PC12h cells. It has been reported that K-252a 
is a potent inhibitor of C  kinase and cyclic nucleotide-de- 
pendent protein kinases (17, 32). K-252a inhibits these pro- 
tein kinases competitively with respect to ATP (17). Indeed, 
K-252a inhibited the effect of  dibutyryl cAMP on phosphory- 
lation of proteins in intact PC12h cells. This indicates that 
K-252a exactly acts as a kinase inhibitor in these cells. How- 
ever,  a much higher concentration of K-252a was required 
to inhibit the action of dibutyryl cAMP than to inhibit the ac- 
tion of NGF in these cells. Therefore, it seems unlikely that 
K-252a prevents NGF action via the inhibition of cAMP-de- 
pendent protein kinase. Some other protein kinases, includ- 
ing myosin light chain kinase and tyrosine kinase, are also 
inhibited by this agent (26;  Dr.  Matsuda  [Kyowa  Hakko 
Kogyo Co. Ltd., Tokyo Research Laboratories], unpublished 
data). The datapresented here indicate that K-252a causes a 
fairly selective  inhibition of NGF-sensitive kinase(s).  In- 
deed, K-252a selectively prevented the effects of NGF on the 
phosphorylation of proteins including tyrosine hydroxylase, 
36,500-D  protein,  35,000-D  protein,  and Nspl00  without 
any remarkable alterations on the phosphorylation of other 
proteins in my experiments. Moreover, K-252a and NGF had 
an  opposite  effect on  the  phosphorylation of proteins  in 
PC12h  cells.  On  the  other hand,  our previous  work has 
shown that wheat germ agglutinin and NGF also show oppo- 
site effects on the phosphorylation of proteins including tyro- 
sine hydroxylase, 35,000-D protein, and Nspl00 and that this 
agglutinin also prevents the effect of NGF on the phosphory- 
lation of proteins as did K-252a in this study. The inhibition 
is produced by the binding of this lectin to the sialic acid 
residues of the NGF receptor (14, 31), which in turn blocks 
the binding of NGF to its receptor and probably deprives the 
cell of a functional receptor. 
The addition of K-252a to the cultures blocked both NGF- 
dependent regeneration of neurites by PC12h cells, which 
had been primed by long-term preexposure to NGF,  and 
NGF-induced priming. It appears, therefore, that both tran- 
scription-independent and -dependent components,  which 
must be activated by the binding of NGF to its receptors 
to promote neurite outgrowth, are suppressed by K-252a. 
These data suggest that both of these components must be in- 
volved in at least one phosphorylation step that can be sup- 
pressed by K-252a, if this agent acts only on protein kinases. 
The idea that two separable components required for NGF- 
induced neurite formation participate in the phosphorylation 
step is supported by the observation that methyltransferase 
inhibitors such as 5'-S-methyl adenosine and 5'-S-(2-methyl- 
propyl)-adenosine, which block NGF-induced neurite for- 
mation by the blockade of both transcription-dependent and 
-independent components, also inhibit changes in the phos- 
phorylation of proteins including tyrosine hydroxylase (28). 
Furthermore, it has also been reported that lithium ion in- 
hibits NGF-induced neurite outgrowth without having any 
effect on NGF-promoted priming, suggesting that this ion 
may block  a  step  in  which the  transcription-independent 
component is involved and inhibits NGF-induced changes in 
the phosphorylation of microtubule-associated proteins (4). 
At  this  point,  the  exact  mechanism by  which  K-252a 
blocks the NGF action is unknown. Some other possibilities, 
for instance that K-252a affects some specific ATP-requiring 
enzyme in its activity, cannot be ruled out. To identify the ex- 
act site(s) on which K-252a acts, further studies are required. 
After this manuscript was  submitted,  results  similar to 
some of those reported here appeared elsewhere (18). 
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